NCT06552169: REgulatory T Cell Therapy to Achieve Immunosuppression REduction
- State
- Under way
- Phase
- Phase 2
- People
- 34 planned
- Started
- 13 Jun 2025
- Primary completion
- Dec 2027
- Arms
- Arm 2A: TRACT/MONO mTOR
- Results
- None posted
- 13 Aug 2024: Trial registered
- 13 Jun 2025: Trial started